PUBLISHER: The Business Research Company | PRODUCT CODE: 1945461
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945461
A laser atherectomy device is a medical instrument designed to employ laser energy for breaking down and removing blockages from blood vessels. This device is commonly utilized in the treatment of conditions such as peripheral artery disease (PAD) or atherosclerosis, where plaque buildup in the arteries leads to narrowing or blockages. The laser atherectomy device operates by delivering a high-energy laser beam to the plaque, causing it to vaporize and facilitating the removal of the blockage.
The primary types of laser atherectomy devices include those with computer control and others. Computer control involves the utilization of computer technology to manage and control various systems and processes. These devices find applications in cardiovascular, peripheral vascular, and neurovascular procedures and are employed by hospitals and surgical centers, ambulatory care centers, and other medical facilities.
Tariffs are impacting the laser atherectomy devices market by increasing costs of imported laser generators, optical fibers, control software, electronic components, and precision manufacturing equipment. Cardiovascular hospitals and surgical centers in North America and Europe are most affected due to reliance on advanced imported laser systems, while Asia-Pacific faces higher export and production costs. These tariffs are raising device acquisition costs and slowing adoption in smaller care settings. However, they are also encouraging domestic innovation, localized assembly of laser systems, and development of cost-optimized atherectomy technologies.
The laser atherectomy devices market research report is one of a series of new reports from The Business Research Company that provides laser atherectomy devices market statistics, including laser atherectomy devices industry global market size, regional shares, competitors with a laser atherectomy devices market share, detailed laser atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the laser atherectomy devices industry. This laser atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The laser atherectomy devices market size has grown strongly in recent years. It will grow from $1.3 billion in 2025 to $1.41 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising prevalence of peripheral artery disease, increasing incidence of cardiovascular disorders, expansion of catheter-based interventions, availability of advanced laser technologies, growth of interventional cardiology centers.
The laser atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular treatments, rising adoption of image-guided interventions, expansion of outpatient cardiovascular procedures, technological advancements in laser systems, growing focus on reducing restenosis rates. Major trends in the forecast period include increasing adoption of laser-based plaque removal techniques, rising use of computer-controlled atherectomy systems, growing demand for minimally invasive vascular interventions, expansion of peripheral and neurovascular applications, enhanced focus on precision and procedural safety.
The laser atherectomy devices market is also anticipated to witness growth due to the rising incidence of cardiovascular diseases (CVD). CVD encompasses diseases affecting the heart or blood vessels, impacting the circulatory system. The surge in cardiovascular diseases leads to an increased number of patients requiring treatment for arterial occlusions and atherosclerotic plaque, thereby creating a higher demand for laser atherectomy devices. For example, in October 2024, data released by the Centers for Disease Control and Prevention, a United States-based government agency, indicated that in 2023 cardiovascular diseases were responsible for 919,032 deaths, representing approximately one out of every three deaths nationwide. Coronary heart disease remained the most common form of heart disease, and notably, nearly one in six cardiovascular-related deaths occurred among adults under the age of 65. Therefore, the growth of cardiovascular diseases propels the laser atherectomy devices market.
Prominent companies in the laser atherectomy devices market are also investing efforts in developing advanced solutions, such as atherectomy platforms, to meet the demands of larger customer bases, drive more sales, and enhance revenue. An atherectomy platform constitutes a comprehensive system or set of tools designed for treating atherosclerosis-a medical condition characterized by plaque buildup in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced FDA clearance for the FreedomFlow, an orbital atherectomy peripheral platform. The distinctive feature of the FreedomFlow platform lies in its contemporary mechanism of action tailored to clear plaque blockages in leg arteries. Its exclusive catheter-based design leverages angular momentum physics, creating a spiral geometry that ensures simultaneous contact with the vessel wall during both advancement and retraction through the incorporation of five diamond-coated spheres. Additionally, a diamond-coated tip facilitates the smooth passage of the driveshaft through narrow blockages. This innovative approach provides physicians with an exceptionally efficient, effective, and adaptable means of treating complex Peripheral Artery Disease (PAD) across a broad spectrum of vessel diameters, ranging from 2 mm in the ankle to 8 mm in the hip. The platform offers greater versatility in addressing multiple arteries and multiple blockages within the same vessel, all achieved with a single device.
In April 2023, Abbott Laboratories, a US-based medical device company, completed the acquisition of Cardiovascular Systems, Inc. for an undisclosed amount. This strategic move enhances Abbott's capabilities to address vascular disease by incorporating CSI's leading atherectomy system designed to prepare vessels for angioplasty or stenting, ultimately restoring blood flow. The acquisition aligns with Abbott's broader investment strategy in its vascular portfolio, fortifying its ability to deliver comprehensive care for patients dealing with peripheral and coronary artery disease. Cardiovascular Systems Inc., a US-based manufacturer of atherectomy devices, now operates as part of Abbott's portfolio.
Major companies operating in the laser atherectomy devices market are Boston Scientific Corporation, Abbott Laboratories, Avinger Inc., AngioDynamics Inc., Cardiovascular Systems Inc., Eximo Medical Ltd., Straub Medical AG, Shockwave Medical Inc., Terumo Corporation, Cordis Corporation, Cook Medical LLC, Biotronik SE & Co. KG, Acotec Scientific Holdings Ltd., Rex Medical LP, ArioMedica Ltd., Advanced Catheter Therapies Inc., B. Braun SE, Olympus Corporation, Koninklijke Philips N.V., Medtronic plc
North America was the largest region in the laser atherectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period. The regions covered in the laser atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the laser atherectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The laser atherectomy devices market consists of sales of turbo elite, diamondback 360, phoenix atherectomy system, jetstream atherectomy system, hawkone system, and ocelot system. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Laser Atherectomy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses laser atherectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for laser atherectomy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The laser atherectomy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.